NR2F2 and prostate carcinoma: Dysregulation of the miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to prostate cancer metastasis, with microRNA-382 inhibiting prostate cancer cell proliferation and metastasis through targeting COUP-TFII [23-25].